The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the matter ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...

Lawmakers sent the attorney general's budget back to committee over concerns about a vaping amendment that would have been a ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

SS Innovations Internationals, a developer of robotic surgical technology, is making its Nasdaq debut. The Fort Lauderdale ...

The FDA previously granted the Tango Belt "breakthrough device designation" in 2023, making it eligible for expedited review ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

A Senate panel has advanced three sets of bipartisan bills purportedly aimed at reforming the intellectual property (IP) ...